Evaluation of cephalosporins utilization and compliance with reference to the hospital antibiotic policy of an Indian tertiary care hospital
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20191599Keywords:
Antibiotics utilization evaluation, Antibiotic policy, Compliance, CephalosporinsAbstract
Background: Emergence of bacterial resistance in hospital settings due to the liberal use of antibiotics which led to an altered impact on its therapeutic efficacy and outcome, thereby increasing the treatment costs in patients. In this regard the study aims to evaluate the cephalosporins utilization and compliance to the hospital antibiotic policy in general medicine ward.
Methods: A prospective observational study was carried out over an eleven-month period in patients prescribed with cephalosporins. Clinical data of inpatients were collected and evaluated by using World Health Organization (WHO) core prescribing indicators and defined daily dose per 100 bed-days. The comparison between the cephalosporins prescribed in the chart records to the recommendations mentioned in the institutional antibiotic policy v.2.0, help to determine the deviations in their usage pattern.
Results: A total of 370 patients were enrolled in the study, of which 54.6% were females. Cephalosporins were empirically prescribed in 240 (64.9%) cases. The average number of total antibiotics and cephalosporins per encounter was 1.6 and 1 respectively. Among the total antibiotics, 63.7% were cephalosporins. Third generation cephalosporins (98.4%) were commonly prescribed, with ceftriaxone (93%) in parenteral form for respiratory tract infections (31.9%). Total parenteral antibiotics prescribed were found to be 68.8% of which 88.6% were cephalosporins. Utilization pattern of cephalosporins amounted to be 4.95 DDD/100 bed-days. Overall compliance was achieved in 191 (51.6%) prescriptions.
Conclusions: The rate of prescribing of cephalosporins was marginally high. There was a low rate of compliance towards policy which reflects the urgent need for repetitive intervention to comply antibiotic policy.
Metrics
References
Thu T, Rahman M, Coffin S, Harun-Or-Rashid M, Sakamoto J, Hung N. Antibiotic use in Vietnamese hospitals: A multicenter point-prevalence study. Am J Infect Control. 2012;40(9):840-4.
Hulscher ME, Grol RP, van der Meer JW. Antibiotic prescribing in hospitals: a social and behavioral scientific approach. Lancet Infect Dis. 2010;10:167-75.
Finch R. Antimicrobial therapy: principles of use. Medicine. 2005;33:42-6.
Tünger Ö, Dinç G, Özbakkaloglu B, Atman Ü, Algün Ü. Evaluation of rational antibiotic use. Int J Antimicrob Agents. 2000;15(2):131-5.
Gururaja MP, Sarah A, Samaga L, Joshi H, Nair S, Shastry CS. Cephalosporin utilization evaluation in a university teaching hospital: prospective study. J Drug Deliv Therapeut. 2013;3(2):83-7.
Ganguly NK, Arora NK, Chandy SJ, Fairoze MN, Gill JP, Gupta U, et al. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res. 2011;134:281-94.
Reddy ES, Reza DH, Sankar B, Mubarak A, Ahamadasafnamariyam. Drug utilization evaluation of cephalosporins in the general medicine and general surgery departments in a Tertiary care teaching hospital. Am J Pharm Health Res. 2015;3(6):2321-3647.
Ayinalem G, Gelaw B, Belay A, Linjesa J. Drug use evaluation of ceftriaxone in medical ward of Dessie Referral Hospital, North East Ethiopia. Int J Chem Natur Sci. 2013;1(1):12-6.
Abebe FA, Derbew F, Berhe DF, Berhe AH, Hishe HZ, Akaleweld MA. Drug use evaluation of Ceftriaxone: the case of Ayder Referral Hospital, Mekelle, Ethiopia. IJPSR. 2012;3(7):2191-5.
Christopher J, Denis B. Cephalosporins: A review. Pediatrics in review. 2008;29(8):264-73.
WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment Oslo; 2016.
Gordana P, Zorica J, Kavin V. Application of the ATC/DDD methodology to compare antibiotic utilization in two university hospital surgical departments. Med Biol. 2005;12(3):174-8.
Vooss AT, Diefenthaeler HS. Evaluation of prescription indicators established by the WHO in Getulio Vargas - RS. Braz J Pham Sci. 2011;47(2):385-90.
Sözen H, GönenI, Sözen, A, Kutlucan A, Kalemci S, Sahan M. Application of ATC/DDD methodology to evaluate of antibiotic use in a general hospital in turkey. Ann Clin Microbiol Antimicrob. 2013;12(1):23.
Hospital Infection Control Committee, Antibiotic Policy, version 2.0, 1.11.2016. Pune: Bharati Vidyapeeth (Deemed to be University) Medical College Hospital and Research Center; 2016:1-63.
Venkatesh S, Chauhan LS, Gadpayle AK, Jain, TS, Ghafur A, Wattal C et al., National Treatment Guidelines for Antimicrobial Use in Infectious Diseases. India: National Centre For Disease Control, MOHFW, Government of India; 2011l:1-64.
Kaliamoorthy K, Sankaralinjam R, punniyakotti S, Janardhan V, Cheekala UMR. Drug utilization evaluation of third generation cephalosporins using core drug use indicators. Pak J Pharm Sci. 2012;25(2):339-42.
Shankar P, Subish P, Upadhyay D, Dubey A, Deshpande V. Cephalosporin utilization in the inpatient wards of a teaching hospital in Western Nepal. JIOM. 2005;27:7-12.
Shankar RP, Partha P, Shenoy NK, Easow JM, Brahmadathan KN. Prescribing patterns of antibiotics and sensitivity patterns of common microorganisms in the Internal Medicine ward of a teaching hospital in western Nepal: a prospective study. Ann Clin Microbiol Antimicrob. 2003;2:7.
Arul B, Rangabashyam SR, Kothai R, Bobby MT, Elavarasi M, Glory MA. Drug utilization review of cephalosporins in a tertiary care hospital: a retrospective study. World J Pharm Pharm Sci. 2017;6(9):1737-43.
Chin V, Harding HE, Tennant I, Soogrim D, Gordon-Strachan GM, Frankson MA. Dynamics of antibiotic usage in the intensive care unit at the University hospital of the West Indies. West Indian Med J. 2010;59(2):159-64.
Babu J, Jyothi K. Drug utilization evaluation of cephalosporins in general medicine units of rural tertiary care hospital. Int J Curr Pharm Res. 2012;4(2):88-91.
Sileshi A, Tenna A, Feyissa M, Shibeshi W. Evaluation of ceftriaxone utilization in medical and emergency wards of Tikur Anbessa specialized hospital: a prospective cross sectional study. BMC Pharmacol Toxico. 2016;17:7.
Abou-Shaaban M, Ali A, Rao P, Majid A. Drug utilization review of cephalosporins in a secondary care hospital in United Arab Emirates. Int J Clin Pharm. 2016;38(6):1367-71.
Marion B, Tony MK, Jonathan GA. Ceftriaxone and cefotaxime use in Victorian hospitals. Med J Aust. 2002;176(11):524-9.
Kheder SI. Cephalosporin Usage and Resistance Trend in a Sudanese Hospital Surgical Wards. JPBMS. 2011;11(11).
Pinto Pereira L, Phillips M, Ramlal H, Teemul K, Prabhakar P. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy. BMC Infect Dis. 2004;4(1):59.
Ayele AA, Gebresillassie BM, Erku DA, Gebreyohannes E, Demssie DG, Mersha AG, et al. Prospective evaluation of Ceftriaxone use in medical and emergency wards of Gondar university referral hospital, Ethiopia. Pharmacol Res Perspect. 2018;6(1):e00383.
Isah AO, Ross-Degnan D, Quick J, Laing R, Mabadeje AFB. The development of standard values for the WHO drug use prescribing indicators. ICUM/EDM/WHO. Available at: http://www.archives.who.int/prduc2004/rducd/ICIUM_ Posters/1a2_txt.html. Accessed 16 Aug 2016.
Nathwani D. How do you measure the impact of an antibiotic policy? J Hosp Infect. 1999;43(Suppl):265-8.